corecivic inc. - CXW
CXW
Close Chg Chg %
18.61 0.01 0.05%
Closed Market
18.62
+0.01 (0.05%)
Volume: 735.90K
Last Updated:
Dec 4, 2025, 3:59 PM EDT
Company Overview: corecivic inc. - CXW
CXW Key Data
| Open $18.54 | Day Range 18.48 - 18.71 |
| 52 Week Range 15.96 - 23.85 | Market Cap $1.95B |
| Shares Outstanding 104.59M | Public Float 101.63M |
| Beta 0.67 | Rev. Per Employee N/A |
| P/E Ratio 18.25 | EPS $1.01 |
| Yield 0.00% | Dividend $0.44 |
| EX-DIVIDEND DATE Mar 31, 2020 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.26M |
CXW Performance
| 1 Week | 3.05% | ||
| 1 Month | 9.73% | ||
| 3 Months | -5.44% | ||
| 1 Year | -13.57% | ||
| 5 Years | 136.64% |
CXW Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
4
Full Ratings ➔
About corecivic inc. - CXW
CoreCivic, Inc. operates as a government solutions company, which engages in the development and management of prisons and other correctional facilities. It operates through the following segments: Safety, Community, and Properties. The Safety segment consists of correctional and detention facilities. It provides transportation services to government agencies and TransCoR. The Community segment offers residential reentry centers and provides electronic monitoring case management services. The Properties segment consists of real estate properties owned by the company that are leased to government agencies. The company was founded by Thomas W. Beasley, T. Don Hutto, and Robert Crants on January 28, 1983 and is headquartered in Brentwood, TN.
CXW At a Glance
CoreCivic, Inc.
5501 Virginia Way
Brentwood, Tennessee 37027
| Phone | 1-615-263-3000 | Revenue | 1.96B | |
| Industry | Miscellaneous Commercial Services | Net Income | 68.87M | |
| Sector | Commercial Services | 2024 Sales Growth | 3.428% | |
| Fiscal Year-end | 12 / 2025 | Employees | 11,649 | |
| View SEC Filings |
CXW Valuation
| P/E Current | 17.896 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 35.019 |
| Price to Sales Ratio | 1.239 |
| Price to Book Ratio | 1.599 |
| Price to Cash Flow Ratio | 9.03 |
| Enterprise Value to EBITDA | 10.506 |
| Enterprise Value to Sales | 1.694 |
| Total Debt to Enterprise Value | 0.305 |
CXW Efficiency
| Revenue/Employee | 168,396.086 |
| Income Per Employee | 5,911.924 |
| Receivables Turnover | 6.794 |
| Total Asset Turnover | 0.642 |
CXW Liquidity
| Current Ratio | 1.574 |
| Quick Ratio | 1.574 |
| Cash Ratio | 0.427 |
CXW Profitability
| Gross Margin | 17.347 |
| Operating Margin | 9.594 |
| Pretax Margin | 4.688 |
| Net Margin | 3.511 |
| Return on Assets | 2.253 |
| Return on Equity | 4.636 |
| Return on Total Capital | 2.748 |
| Return on Invested Capital | 2.685 |
CXW Capital Structure
| Total Debt to Total Equity | 67.825 |
| Total Debt to Total Capital | 40.414 |
| Total Debt to Total Assets | 33.666 |
| Long-Term Debt to Equity | 66.799 |
| Long-Term Debt to Total Capital | 39.803 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Corecivic Inc. - CXW
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.86B | 1.85B | 1.90B | 1.96B | |
Sales Growth
| -2.25% | -0.93% | +2.78% | +3.43% | |
Cost of Goods Sold (COGS) incl D&A
| 1.47B | 1.54B | 1.59B | 1.62B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 134.74M | 127.91M | 127.32M | 128.01M | |
Depreciation
| 132.84M | 126.61M | 126.82M | 127.51M | |
Amortization of Intangibles
| 1.90M | 1.30M | 500.00K | 500.00K | |
COGS Growth
| -5.49% | +4.75% | +3.12% | +1.99% | |
Gross Income
| 390.81M | 303.63M | 306.89M | 340.28M | |
Gross Income Growth
| +12.22% | -22.31% | +1.07% | +10.88% | |
Gross Profit Margin
| +20.98% | +16.45% | +16.18% | +17.35% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 135.77M | 127.70M | 136.08M | 152.08M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 135.77M | 127.70M | 136.08M | 152.08M | |
SGA Growth
| +9.19% | -5.94% | +6.57% | +11.76% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 121.95M | 14.37M | 3.40M | 34.42M | |
EBIT after Unusual Expense
| 133.09M | 161.56M | 167.41M | 153.77M | |
Non Operating Income/Expense
| 48.55M | 99.61M | 1.37M | 5.61M | |
Non-Operating Interest Income
| - | - | 10.00M | 10.90M | - |
Equity in Earnings of Affiliates
| (138.00K) | (124.00K) | 325.00K | 2.30M | |
Interest Expense
| 95.54M | 95.87M | 72.96M | 67.42M | |
Interest Expense Growth
| +14.70% | +0.35% | -23.90% | -7.60% | |
Gross Interest Expense
| 95.54M | 95.87M | 72.96M | 67.42M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 86.10M | 165.30M | 95.82M | 91.96M | |
Pretax Income Growth
| +44.17% | +91.98% | -42.03% | -4.03% | |
Pretax Margin
| +4.62% | +8.96% | +5.05% | +4.69% | |
Income Tax
| 138.00M | 42.98M | 28.23M | 23.09M | |
Income Tax - Current - Domestic
| 38.73M | 31.52M | 30.94M | 30.80M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| 99.27M | 11.46M | (2.70M) | (7.71M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| (138.00K) | (124.00K) | 325.00K | 2.30M | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (51.90M) | 122.32M | 67.59M | 68.87M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (51.90M) | 122.32M | 67.59M | 68.87M | |
Net Income Growth
| -195.83% | +335.70% | -44.74% | +1.89% | |
Net Margin Growth
| -2.79% | +6.63% | +3.56% | +3.51% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (51.90M) | 122.32M | 67.59M | 68.87M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (51.90M) | 122.32M | 67.59M | 68.87M | |
EPS (Basic)
| -0.4318 | 1.0349 | 0.594 | 0.6208 | |
EPS (Basic) Growth
| -193.30% | +339.67% | -42.60% | +4.51% | |
Basic Shares Outstanding
| 120.19M | 118.20M | 113.80M | 110.94M | |
EPS (Diluted)
| -0.4318 | 1.027 | 0.5895 | 0.6208 | |
EPS (Diluted) Growth
| -196.43% | +337.84% | -42.60% | +5.31% | |
Diluted Shares Outstanding
| 120.19M | 119.10M | 114.65M | 111.84M | |
EBITDA
| 389.78M | 303.84M | 298.12M | 316.21M | |
EBITDA Growth
| +4.01% | -22.05% | -1.88% | +6.07% | |
EBITDA Margin
| +20.93% | +16.47% | +15.72% | +16.12% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 30.917 | |
| Number of Ratings | 4 | Current Quarters Estimate | 0.184 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 1.012 | |
| Last Quarter’s Earnings | 0.24 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.62 | Next Fiscal Year Estimate | 1.52 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 5 | 3 | 5 | 4 |
| Mean Estimate | 0.18 | 0.28 | 1.01 | 1.52 |
| High Estimates | 0.23 | 0.37 | 1.06 | 1.79 |
| Low Estimate | 0.14 | 0.22 | 0.96 | 1.37 |
| Coefficient of Variance | 19.06 | 28.35 | 3.79 | 12.21 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 4 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Corecivic Inc. - CXW
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Corecivic Inc. - CXW
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| May 21, 2025 | Anthony L. Grande EVP, Chief Development Officer | 180,559 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.22 per share | 4,012,020.98 |
| May 20, 2025 | Stacey Tank Director | 6,482 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $21.92 per share | 142,085.44 |
| May 20, 2025 | Cole G. Carter EVP,General Counsel, Secretary | 207,872 | Bona fide gift Non-derivative transaction at $21.72 per share | 4,514,979.84 |
| May 20, 2025 | S. Dawn Smith Director | 6,482 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $21.92 per share | 142,085.44 |
| May 20, 2025 | Mark A. Emkes Director | 160,099 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $21.92 per share | 3,509,370.08 |
| May 20, 2025 | Nina A. Tran Director | 6,482 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $21.92 per share | 142,085.44 |
| Feb 26, 2025 | Damon T. Hininger CEO; Director | 1,080,075 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | David K. Churchill Chief Human Resources Officer | 168,120 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $18.02 per share | 3,029,522.40 |
| Feb 26, 2025 | Lucibeth N. Mayberry EVP, Chief Innovation Officer | 278,762 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $18.02 per share | 5,023,291.24 |
| Feb 26, 2025 | Lucibeth N. Mayberry EVP, Chief Innovation Officer | 324,112 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | Cole G. Carter EVP,General Counsel, Secretary | 231,402 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $18.02 per share | 4,169,864.04 |
| Feb 26, 2025 | Damon T. Hininger CEO; Director | 951,570 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $18.02 per share | 17,147,291.40 |
| Feb 26, 2025 | Anthony L. Grande EVP, Chief Development Officer | 183,089 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $18.02 per share | 3,299,263.78 |
| Feb 26, 2025 | Patrick D. Swindle President & COO | 264,630 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $18.02 per share | 4,768,632.60 |
| Feb 26, 2025 | Patrick D. Swindle President & COO | 309,615 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | David M. Garfinkle EVP & Chief Financial Officer | 332,361 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $18.02 per share | 5,989,145.22 |
| Feb 26, 2025 | David M. Garfinkle EVP & Chief Financial Officer | 378,598 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 26, 2025 | David K. Churchill Chief Human Resources Officer | 210,275 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Robert J. Dennis Director | 84,426 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 21, 2025 | Thurgood Marshall Director | 50,023 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |